National (Brazil), Phase IV, Multicentric, Open Label, Parallel, Comparative Study of the Use of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2013
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Insulin; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DINAMO
- Sponsors Sanofi
- 07 Jun 2017 Biomarkers information updated
- 01 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.